NCT00236951View on ClinicalTrials.gov

Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

October 31, 2005

Study Completion Date

December 31, 2005

Conditions
Anemia
Interventions
DRUG

iron sucrose injection USP

DRUG

stable erythropoietin therapy

Sponsors
All Listed Sponsors
lead

American Regent, Inc.

INDUSTRY